– Kirchner Group advises Exosect on Monsanto transaction –
Published: July 18th, 2018
July 18th, 2018 – Kirchner Group is pleased to announce that it acted as advisor to Exosect Limited in connection with a licensing agreement with Monsanto Company related to the use of certain Exosect technology in seed treatments. A copy of the Exosect announcement can be viewed here.
Exosect is a lean formulations company that exploits the characteristics of their unique, proprietary technology platforms. They apply their extensive formulations know-how to enable the efficient, targeted delivery of biological and synthetic active ingredients. The technology platforms deliver a unique mix of commercial and environmental benefits.
“We are pleased to have assisted with this transaction for our client which illustrates the technology’s significant benefits for delivery of microbes and positions it for wide adoption,” commented Armand Lavoie, Managing Director and Head of Agriculture and Food at Kirchner Group. “It is an exciting time in the AgTech space and we are proud to be a leading boutique advisor to early stage and mid-market companies in the sector as they explore their strategic options.”
Additional details on the transaction were not disclosed.
Kirchner Group was founded in 1985 as a boutique advisory firm and today operates various subsidiaries, providing advisory services (M&A, assessments, diligence) and operational support (interim management, workouts, turnarounds) as well as asset management (dedicated, underperforming funds) – all leveraging a proprietary approach that dovetails domain and process expertise.
Throughout the decades Kirchner Group has been internationally recognized for its unique business model centered around creating value while promoting values – “earning while returning”. The firm has also established a reputation for building and rebuilding important business and social paradigms based on its deep entrepreneurial orientation.
Kirchner Group’s clients and partners include early stage to mid-market companies, venture capital and private equity firms as well as family offices and some of the world’s largest insurance companies, commercial banks and institutional investors. www.kirchnergroup.com